New therapeutic drugs approved in both countries totalled 301; 86 (28.6%) and 136 (45.2%) were given priority review status in Canada and the United States
New therapeutic drugs approved in both countries totalled 301;86 (28.6%) and 136 (45.2%) were given priority review status in Canada and the United States